by Raynovich Rod | Jan 27, 2025 | 2024 Rayno Tools and Diagnostics Portfolio, 2024-25 Life Science Portfolios, 2025 Rayno Biopharmaceuticals Portfolio
Looks Good for Biotech Stocks-Why we are bullish. Technicals and Relative Strength (RSI) are lined up for bullish trades and good momentum. Biopharmaceuticals offer good value and new themes such as obesity and neuroscience. Innovation and M&A will drive SMID caps...
by Raynovich Rod | Jan 20, 2025 | 2024-25 Life Science Portfolios, 2025 Rayno Biopharmaceuticals Portfolio, Biopharmaceuticals
Update-2 1/23/25…Biotech SMIDs continue to rally: Added to BMY with a 4% yield and strong technicals. Momentum ETFS in biotech up :ARKG XBI. Check SMID trading list: ADPT, BBIO, EXEL,GH, PTGX etc. LARGE CAPS look solid: BMY, GSK, LLY, NVS,...
by Raynovich Rod | Jan 6, 2025 | 2024-25 Life Science Portfolios, 2025 Rayno Biopharmaceuticals Portfolio
Update-3 1/12/25….It’s JPM Healthcare Week with markets under pressure from rising rates and so many changes going on. XLV stalled at $140 level down over 0.945 over one year, XBI and IBB actually down over one year. Bank earnings an and inflation data in...
by Raynovich Rod | Dec 23, 2024 | 2024-25 Life Science Portfolios, 2025 Rayno Biopharmaceuticals Portfolio
Update-1…DEC 27 a low volume trading day and the sellers have come on early as investors and traders rebalance their portfolios.And tax considerations play a big role.But SMID biotechs are trading actively and yesterday despite the XBI up less than 1% we saw...
by Raynovich Rod | Nov 7, 2024 | 2024-25 Life Science Portfolios, Clinical Diagnostics and Tools
11:11 am on 11/11/24….SMID rally continues led by ETFs and seasonally XBI up 0.85% to $105 level. STRONG MOVERS: ARKG, ADPT, CRBU, CRMD,CYRX, DNLI, EVH, PACB, VCYT etc SMID Biotech Stocks are Primed for GOOD GAINS With election uncertainty over and a benign...
by Raynovich Rod | Oct 29, 2024 | 2024-25 Life Science Portfolios, 2025 Rayno Biopharmaceuticals Portfolio
Update-2 11/1/24…Market recovered from big losses yesterday with some buying in to XBI to the $99 level again.IBB remains choppy but up about 1% for the week. LOTS of green among SMID caps today: ADPT, CRBU, CRSP, DNLI, ILMN, EXEL, PACB,TEM etc. KUDOS to...
by Raynovich Rod | Oct 7, 2024 | 2024-25 Life Science Portfolios, 2025 Rayno Biopharmaceuticals Portfolio
Update-1 10/11..3:30P SMID cap rally underway . Check list below for movers. ARKG up 3.9%.XBI up 2.25% off bottom. MOVERS: CRBU,CRMD, DNLI,ILMN,NTRA,SUPN,TEM ,TWST,PACB, VCEL, VCYT, etc. Strong earnings from banks supports bullish outlook through end of year....
by Rod Raynovich | Sep 2, 2024 | 2024-25 Life Science Portfolios, 2025 Rayno Biopharmaceuticals Portfolio, Biopharmaceuticals
Update-3 9/11..Selective SMID biotechs ran up today along with the mid day reversal in the tech stocks showing speculative interest remains in the market. Watch ARKG and XBI for strength. Some big movers this week: ADPT,CRBU CRMD,DNLI, NTRA, ROIV,VCYT. But SUPN was...
by Raynovich Rod | Aug 20, 2024 | 2024-25 Life Science Portfolios, Biopharmaceuticals
Update-2 8/26/24….On a 3 day weekend so no new post till Wednesday. It’s a quiet week with many people taking off before Labor Day weekend. Some big SMID movers today so check them out: CRMD up over 9% , DNLI up 3.31%, IMTX up over 3%, RZLT up 8%, All...
by Raynovich Rod | Jul 22, 2024 | 2024-25 Life Science Portfolios, 2025 Rayno Biopharmaceuticals Portfolio, Biopharmaceuticals
Update-1 JY 24…Healthcare Stocks held up well during today’s technology sell-off. NASDAQ stocks took a big hit today with the QQQ down 3.59%.We can say it was caused by the Google earnings report as technology analysts tried to read beyond the actual...
